Latest News
IONTAS announces Mammalian Display licensing agreement with Bristol Myers Squib
IONTAS’ mammalian display technology facilitates the identification of high affinity developable full-length antibody libraries in the context of mammalian cells Cambridge, UK – 13 October 2020 – IONTAS Limited (IONTAS), an innovative biotechnology company focused on...
IONTAS and FairJourney Biologics Discover SARS-CoV-2 Neutralizing Antibodies with Picomolar Potency
IONTAS and FairJourney Biologics Discover SARS-CoV-2 Neutralizing Antibodies with Picomolar Potency · Panel of 15 potent antibodies selected that are optimally suited to clinical development and manufacturing · Monoclonal antibodies have the potential to both...
FairJourney Biologics Listed in Deloitte Fast 500
We are pleased to announce that FairJourney Biologics has been named as one of the 500 fastest-growing EMEA tech companies in the Deloitte Technology Fast 500 with FairJourney ranking 293 recognising the company's 439 percent growth. Full list can be found...
IONTAS announces Mammalian Display licensing agreement with Bristol Myers Squib
IONTAS’ mammalian display technology facilitates the identification of high affinity developable full-length antibody libraries in the context of mammalian cells Cambridge, UK – 13 October 2020 – IONTAS Limited (IONTAS), an innovative biotechnology company focused on...
